Skip to main content
. 2021 Feb 18;2(1):100345. doi: 10.1016/j.xpro.2021.100345

Table 2.

Dose response assays to assess synergy between drug A (e.g., BEZ235 (BEZ)) and drug B (e.g., temozolomide (TMZ))

Tested drug A concentration BEZ 0.1 μM BEZ 0.25 μM BEZ 0.5 μM BEZ 1 μM
TMZ 0
BEZ 0
TMZ 0
BEZ 1 μM
TMZ 0
BEZ 2.5 μM
TMZ 0
BEZ 5 μM
TMZ 0
BEZ 10 μM
Tested drug B concentration
TMZ 10 μM
BEZ 0
TMZ 10 μM
BEZ 1 μM
TMZ 10 μM
BEZ 2.5 μM
TMZ 10 μM
BEZ 5 μM
TMZ 10 μM
BEZ 10 μM
TMZ 1 μM
TMZ 100 μM
BEZ 0
TMZ 100 μM
BEZ 1 μM
TMZ 100 μM
BEZ 2.5 μM
TMZ 100 μM
BEZ 5 μM
TMZ 100 μM
BEZ 10 μM
TMZ 10 μM
TMZ 250 μM
BEZ 0
TMZ 250 μM
BEZ 1 μM
TMZ 250 μM
BEZ 2.5 μM
TMZ 250 μM
BEZ 5 μM
TMZ 250 μM
BEZ 10 μM
TMZ 25 μM
TMZ 500 μM
BEZ 0
TMZ 500 μM
BEZ 1 μM
TMZ 500 μM
BEZ 2.5 μM
TMZ 500 μM
BEZ 5 μM
TMZ 500 μM
BEZ 10 μM
TMZ 50 μM
TMZ 1 mM
BEZ 0
TMZ 1 mM
BEZ 1 μM
TMZ 1 mM
BEZ 2.5 μM
TMZ 1 mM
BEZ 5 μM
TMZ 1 mM
BEZ 10 μM
TMZ 100 μM

TMZ or BEZ are indicated as 10× concentrations and used to achieve final 1× concentrations.